Top executives and innovators come from all over the world to attend The MedTech Conference. Here, the Investor Forum is the perfect path for investors to gain access to can’t-miss panels, exclusive opportunities, and the best of what the conference has to offer.
What's In Store
From insight into the strategic priorities of top medtech companies to one-on-one meetings, you’ll have everything you need to capitalize on the latest industry trends.
2023 Session Snapshot:
- Buy, Partner, Invest or Build? Strategies for Adding Game-Changing Capabilities
- EY Pulse of the Industry: Medical Technology Report 2023
- AdvaMed Accel Leadership Seminar: Strategies for Raising Early-Stage Capital
Sessions
Who You'll See
If you’re an analyst, venture capitalist, institutional investor, or investment banker, you’ll be in good company.
Program Highlights
Below are a few session highlights from our 2022 program. For a comprehensive list of sessions geared towards the investment community from our 2022 program, view our suggested agenda.
Early-stage VC Perspectives on Building Successful Start-ups
Hear perspectives from a broad set of early-stage investors, including funds that focus exclusively on seed and Series A investments, as well as those that more selectively opt to invest in early rounds.
Read more
Alternative Funding Models for High Growth Medtech Companies
Join an expert panel of health care investors, bankers and market-leading strategic acquirers as they dive into the available funding strategies for high growth medical device technologies.
Read more
MedTech Innovator Finals
Five finalist companies from the MedTech Innovator competition will present to a panel of industry-leading judges and compete for the audience vote to win $500,000 in prizes
and the award of MedTech Innovator 2022!
Corporate Reverse Pitch Presentations
These 15-minute presentations will feature global business and corporate development executives presenting their companies’ strategic priorities.
EY Pulse of the Industry
The 16th edition of EY’s Pulse of the Industry report offers a chance to take stock of the US and European medtech industry’s impressive performance during a period of intense global disruption.
Read more
CECP Investor Forum
Taking place on Wednesday, October 26, this program is designed to aid and empower CEOs on their journey to refocus investor expectations toward the long term.
Monday, October 24
AdvaMed Accel Leadership Seminar
8:00 am – 12:00 pm
Networking Breakfast followed by half-day program including Medtech Innovator Execution Award and Virginia Shimer Rybski Memorial Award and two panel sessions.
Plenary Lunch
Reverse Pitch Program
20 Reverse Pitch Presentations from corporate business development, corporate venture mid-size to large member companies
Confirmed Companies: Abbott, Boston Scientific, Edwards, Haemonetics, Hologic, GE Healthcare, Olympus, Siemens, W.L. Gore and Zoll
Networking reception
5:15 pm – 6:15 pm
1-1 partnering
9:30 am – 5:00 pm
Business Strategies Sessions
General Program Sessions
Tuesday, October 25
Reverse Pitch Program
Business Strategies Sessions
Exhibit Hall
MedTech Innovator Showcase, Innovation Pavilion
Plenary Lunch
MedTech Innovator Finals
General Program Sessions
1-1 partnering
9:30 am – 5:00 pm
Wednesday, October 26
Chief Executives for Corporate Purpose (CECP) Program
Business Strategies Sessions
Exhibit Hall
MedTech Innovator Showcase, Innovation Pavilion
Plenary Lunch
General Program Sessions
1-1 partnering
9:30 am – 4:00 pm